05 Jun, EOD - Indian

SENSEX 81442.04 (0.55)

Nifty 50 24750.9 (0.53)

Nifty Bank 55760.85 (0.15)

Nifty IT 37107.95 (0.46)

Nifty Midcap 100 58303 (0.65)

Nifty Next 50 67147.1 (0.42)

Nifty Pharma 21644.2 (1.28)

Nifty Smallcap 100 18432.6 (0.96)

05 Jun, EOD - Global

NIKKEI 225 37554.49 (-0.51)

HANG SENG 23906.97 (1.07)

S&P 5959.25 (0.02)

LOGIN HERE

flagArvee Laboratories (India) Ltd

You are Here : Home > Markets > CompanyInformation > Company Background
BSE Code : 535050 | NSE Symbol : ARVEE | ISIN : INE006Z01016 | Industry : Chemicals |


Company History

Arvee Laboratories (India) Limited was incorporated as a Private Limited Company with the name 'Arvee Laboratories (India) Private Limited' on January 27, 2012 in Ahmedabad, Gujarat. Subsequently, the Company name was changed to Arvee Laboratories (India) Limited upon conversion into a Public Limited Company on September 19, 2017. Presently, the Company is engaged in manufacturing of specialized chemicals.

Initially, the control & management of the Company was with Mr. Bharat Rasiklal Chokshi, Mr Saumil Bharatbhai Chokshi, Mr. Sudhakarbhai Chhotabhai Patel and Mr. Shalin Bharat Chokshi who were the subscribers to the Memorandum of Association. Since, April 01, 2013 the control & management was completely taken over by Mr. Shalin Sudhakarbhai Patel and Mr. Shalin Bharat Chokshi.

The Company started construction of its first plant for Thiophene Derivatives in 2013. It acquired land, building and machineries from Skylink Chemicals Private Limited and started manufacturing unit. It commissioned the Thiophene Derivatives Plant in 2013. In 2014, the Company started construction of plant for Sulfo and Nitro Derivatives of Isophthalic Acid. In 2015, it commissioned the plant for Nitro Derivatives of Isophthalic Acid.

In February 2018, the Company came up with a Public Issue of 14,60,000 Equity Shares by raising money through equity aggregating Rs 8.90 Crore.

The vision of promoters, Mr. Shalin Bharat Chokshi and Mr. Shalin Sudhakarbhai Patel aims at diversifying the activity of manufacturing specialty chemicals like Dimethyl 5-Nitroisphthalate, 2-ThiopheneCarboxaldehyde, 2-Acetyl Thiophene, Lithium Sulpho Isopthalic Acid-LiSIPA, etc that cater to the needs and demands of other businesses in India and overseas. The diversification into other chemicals are based on the yield that a particular chemical is providing by leading to low wastage and high effectiveness. Arvee has established its credibility as an approved vendor in the international market after successfully passing the Quality Audits conducted by various companies of international repute. The plant facilities and other utility services at Arvee are equipped to undertake a host of processes namely: Nitration, Sulfonation, Reduction, Esterification, Hoffman Reaction, Caustic Fusion, etc.

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +